January 4, 2021 -- Thermo Fisher Scientific has completed its acquisition of Phitonex, a North Carolina-based company that has created a spectral dye platform for high-resolution biology applications.
Phitonex's Phiton platform is designed to speed up cell therapy, immuno-oncology, and immunology research and development. The platform acts as a structure to maintain a greater number of fluorescent dyes in specific ways, allowing researchers to obtain more comprehensive cell sample data. It also allows researchers to quickly create multiple different dye labels to increase the number of proteins and cell populations identified in a single experiment.
The acquisition will allow Thermo Fisher to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. Phitonex's product offering is also a natural expansion of the company's existing protein and cell analysis portfolio, according to Thermo Fisher.
Financial details of the acquisition were not disclosed.
Already have an account? Sign in Here
To access all ScienceBoard content create a free account now: